HSBC’s Strategy for India:
– FII inflows into Indian equities reached $21 billion by the end of 2023, with expectations for further growth. Target remains optimistic.
– Large caps are poised for growth due to strong FII inflows, offering a favorable risk-reward profile. Target growth expected.
– Financials are highlighted for their growth potential at attractive valuations. Target valuations look promising.
– A risk-on stance may favor sectors like IT in 2024, given their underperformance in 2023. IT sector target remains under observation.
– HSBC favors India over its regional peers, particularly banks, healthcare, and energy. Target set higher for these sectors.
Jefferies’ Real Estate Outlook:
– Mindspace REIT’s rating is upgraded to “Buy” with a target price of Rs 365.
– Prestige is downgraded to “Underperform” but sees an increased target price of Rs 1,000.
– Sobha’s rating shifts to “Hold” with a target price of Rs 1,265.
– DLF is recommended as a “Buy” with a target price of Rs 875.
– Godrej Prop remains a “Buy” with a new target of Rs 2,635.
– Oberoi Realty is suggested as “Hold” with a target of Rs 1,375.
– Macrotech maintains a “Buy” stance with a target price of Rs 1,290.
– Embassy REIT is retained as “Buy” with a target of Rs 394.
– Sunteck Realty remains a “Buy” with a target price of Rs 555.
Emkay on Zee Entertainment:
– Sony India appears set to withdraw from the merger with Zee Entertainment by 20-Jan-24. Zee’s target price may be impacted.
– Potential merger breakdown could affect both Sony and Zee negatively, given their past growth trends. Targets revised downward due to uncertainty.
– A final decision on the merger is expected soon. If canceled, Zee’s stock could see a significant drop.
JPMorgan on Tata Motors:
– JPMorgan maintains an “Overweight” stance on Tata Motors with a target price of Rs 925.
– Sales trends are positive, but North America lags. Targets are set with cautious optimism.
– Q3 forecasts indicate strong profitability across JLR and India businesses, with targets reflecting this optimism.
– Management’s approach to free cash flow and debt reduction will be closely watched, potentially impacting the stock’s target price.
Jefferies' on Financials Stock
- Nippon AMC: Maintained as a "Buy" with a target price raised to Rs 540 from Rs 440.
- HDFC AMC: Retained as a "Buy" with a target price increased to Rs 3,890 from Rs 3,230.
- KFin Tech: Kept at "Buy" with a target price elevated to Rs 660 from Rs 570.
- Max Financial: Maintained as "Buy" with a target price adjusted to Rs 1,200 from Rs 1,070.
- BSE: Remains a "Buy" with a target price set at Rs 3,000, up from Rs 2,700.
- Life Insurers: Steady growth observed but with concerns over weaker margins. Targets set with caution.
- General Insurers: Positioned well in the market, with target prices indicating positive growth prospects.
- Fintechs: Seen as potential rebound stories, with target prices reflecting optimistic recovery.
- Asset Managers: Benefiting from favorable market conditions, with target prices set at higher levels.
- Exchanges: Capitalizing on market digitization trends, with target prices reflecting growth opportunities.
Morgan Stanley's Insights on Q4 Earnings:
- Profit growth driven by margin improvements.
- Domestically-focused sectors lead in broad growth.
- Anticipate 60% of Morgan Stanley's coverage to see margin growth.
- Expect subdued top-line expansion.
- India remains within a positive earnings cycle.
- Preference for financials, consumer discretionary, and industrials; caution towards sectors reliant on external markets.
- Predict 8% revenue growth and 11% net profit growth for Sensex in Q3FY24.
- Nifty projected at 5% revenue growth and 12% net profit growth for the same period.
Citi Research on India's Mutual Funds Sector:
- December 2023 records equity inflows of Rs 17,000 crore, sustaining growth.
- Anticipate a notable decline in lumpsum net flows compared to the last four months.
- Anticipated rise in NFOs might reduce inflows into current schemes.
Citi Research on Page Industries:
- Target set at 35,400.
- Concerns over near-term revenue and profitability.
- Challenges in athleisure and active wear demand.
- MBO expansion rate decelerating, particularly in kids wear.
- Potential strategy shifts due to recent management alterations.
Citi Research on Bata:
- Target set at 1340.
- Revenue and profitability at risk due to a sluggish discretionary demand environment.
- Slowing expansion of stores and distribution.
- Potential de-rating due to revenue growth lagging peers.
Jefferies on India's Agribusiness Sector:
- 'Buy' recommendation for PI Industries with a target of Rs 4,290.
- SRF downgraded to 'Underperform' with a target of Rs 2,140.
- Neutral stance on Navin Fluorine, awaiting new Managing Director's impact.
- Predicted lag in SRF business recovery despite recent stock performance.
- Growth expected to revert to historical averages by the end of CY24.
HSBC on Nykaa:
- Target price set at 250.
- Nykaa poised to leverage its scale and leadership in the BPC sector.
- Predicted CAGR of 20-30% for the BPC e-commerce market over the next decade.
- Revenue projected to double biennially over the subsequent five years.
Morgan Stanley on India's Auto, Airlines, and Hospitals:
- Auto sector nearing peak volume growth.
- Top preferences: Tata Motors, Ashok Leyland, Mahindra, Maruti, Bajaj Auto.
- In airlines, Interglobe Aviation (Indigo) stands out due to industry consolidation.
- Indian healthcare sector has untapped potential in infrastructure and medical expenditure.
- Apollo hospitals focusing on capex, growth, and margin enhancement.
Sector-wise Q3 Results Preview:
- Nirmal Bang: Chemicals - Revival potential, but timing uncertain.
- Prabhudas Lilladher: Oil & Gas - Anticipate subdued operating outcomes.
- Prabhudas Lilladher: Travel & Tourism - Modest demand for luggage but optimistic about hotels.
- ICICI Securities: Automobiles - Earnings growth catalysts waning.
- Motilal Oswal: Q3 FY24 - Domestic cyclical sectors expected to boost earnings.
- Prabhudas Lilladher: Banks - Sequential decline in core profitability anticipated.
- ICICI Securities: Metals - Positive for miners, but ferrous segment drags.
- Prabhudas Lilladher: Healthcare - Pharma set for robust Ebitda growth, especially in U.S. markets.
